How could the AMA's warning about antibiotic resistance affect Tassal's operations?
Tassal's salmon farming permit faces regulatory review over antibiotic use The Australian Medical Association has urged the regulator to conduct a full assessment of the health and environmental risks associated with the use of florfenicol in salmon farming. This pressure comes as Salmon Tasmania sought a new emergency-use permit for the antibiotic. The AMA argues that florfenicol cannot be contained, potentially exposing aquatic workers, fishers, and wildlife to resistant organisms. The regulator previously revoked an emergency permit due to traces of the antibiotic being detected in wild fish and abalone, meaning the outcome of this new assessment could significantly impact Tassal's ability to treat its farmed salmon.
- Effect
- Strong negative
- How direct
- 2 steps, 2 inferred by Brind
- When
- Within weeks
- The story
- Still developing
How it reaches Tassal
-
The Australian Medical Association warned that rates of antibiotic resistance are surging, noting a 25 per cent rise in critical resistance in 2024. The AMA also urged a federal regulator to assess the human health and environmental risks of antibiotic resistance before approving a permit for florfenicol use in Tasmanian salmon farming.
The full event2independent outlets -
The Australian Medical Association has urged the regulator to conduct a full evaluation of the cumulative environmental and public health effects of repeated, large-scale use of florfenicol. This assessment must consider the risk of resistant bacteria reaching people through water, seafood, and occupational contact.
No report states this step directly. Brind drew it from the reporting on each side of it, so treat it as an informed guess.
-
regulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia
Everything about Therapeutic Goods Administration -
The regulator's decision on the new emergency-use permit request directly determines whether Salmon Tasmania can continue to use florfenicol for treating farmed salmon. This follows a previous permit revocation due to traces of the antibiotic being found in wild fish species up to 10 kilometres from the nearest salmon pen.
No report states this step directly. Brind drew it from the reporting on each side of it, so treat it as an informed guess.
-
Australian public company in the salmon farming aquaculture industry
Everything about Tassal
Tap any step to see the evidence behind it.
The facts so far
As reported. Each one links to where it comes from.
- The AMA urged the regulator to assess health and environmental risks of florfenicol before approving a new permit for Salmon Tasmania.abc.net.au
- The previous emergency permit was revoked in March this year after traces of the antibiotic were detected in wild fish species up to 10 kilometres from the nearest salmon pen.abc.net.au
- The AMA submission stated that florfenicol given in medicated feed to salmon pens cannot be contained.abc.net.au
- The previous permit allowed for 10 to 20 milligrams per kilogram of fish per day for 10 consecutive days.abc.net.au
Why it matters
The use of antibiotics in aquaculture is a critical operational factor for Tassal, allowing them to treat bacterial diseases that could otherwise lead to massive fish losses. If the regulator denies or restricts the permit, Tassal's ability to manage disease outbreaks in its farmed salmon would be severely compromised, potentially leading to significant production losses.
This situation is part of a wider global health crisis, as the AMA warns that antimicrobial resistance is one of the most serious threats of the 21st century. The industry is also under pressure to reduce international trade risks linked to antibiotic use, prompting the move to reduce the use of antibiotics like oxytetracycline.
What we don't know yet
- What specific findings will the regulator use in its full assessment of the environmental and human health risks?
- Will the regulator impose restrictions on the dose rates or treatment frequency if the permit is granted?
Is this still moving?
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
What would change this answer
Who else could feel it
Other possible ripples from the same event.
Reporting
- abc.net.auYesterday
- nvi.com.auTuesday
Keep going
Brind's analysis is written by AI from the reporting linked above and can be wrong. This explainer is a possibility worth considering, not a forecast: steps marked as Brind's reasoning are not stated in the reporting. It is not investment advice; do your own research.